“We were critical of the First Circuit decision in Bartlett v. Mutual Pharm. Co., and called for Supreme Court review. The Supreme Court today reversed the horrifically bad decision—but disturbingly, did so only on a 5-4 vote.” Manhattan Institute Center for Legal Policy Adjunct Fellow Ted Frank, blogging about the Court’s ruling insulating generic drug makers from liability under state law for design-defects.

PointofLaw.com, June 24, 2013.